Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Chemotherapy in Malignant Pleural Mesothelioma
NCT00996567Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Oct 2009
- Primary completion
- Sep 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of cetuximab in malignant pleural mesothelioma (MPM), sponsored by Ghent University Hospital. Started Oct 2009; status: completed.
02
Drugs
cetuximab
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00996567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996567.